1132709-14-8,
((S)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid,
AB01275474-01,
NCGC00181022-01,
CHEMBL524664,
SCHEMBL8035134,
DTXSID30647765,
cid_24871309,
BDBM200228,
HMS2089J16,
AKOS016844850,
ZINC169897614,
NCGC00181022-02,
NCGC00181022-03,
NCGC00181022-04,
NCGC00181022-05,
AX8254900,
179B697,
SR-05000001469,
SR-05000001469-2,
(S)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butylboronic acid,
N-[(1S)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-L-phenylalaninamide,
Bortezomib,
GXJABQQUPOEUTA-DOTOQJQBSA-N,
179324-69-7,
B-[(1S)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic Acid,